# RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling

Study · id `cardio:ct-nct07819643` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07819643](<https://clinicaltrials.gov/study/NCT07819643>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07819643

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT07819643. Randomized; single masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT07819643, source copy `cardio:ctgov-nct07819643-2026-09-15`, retrieved 2026-10-31)
- Planned start: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT07819643, source copy `cardio:ctgov-nct07819643-2026-09-15`, retrieved 2026-10-31)
- Primary completion: 2029-01-01 (anticipated) (ClinicalTrials.gov record NCT07819643, source copy `cardio:ctgov-nct07819643-2026-09-15`, retrieved 2026-10-31)
- Completion: 2029-12-01 (anticipated) (ClinicalTrials.gov record NCT07819643, source copy `cardio:ctgov-nct07819643-2026-09-15`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07819643-2026-09-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
- Acronym: RESCUE
- Condition: Atherosclerosis Cerebral
- Condition: Carotid Plaque
- Condition: Vulnerable Plaque
- Condition: Carotid Stenosis
- Intervention (Drug): Intervention 1
- Intervention (Drug): Intervention 3
- Intervention (Drug): Intervention 2
- Intervention (Drug): Intervention 4
- Lead sponsor: Keqiang Zhao
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)

## Provenance

Content hash: 4ced60c6d9f882a5a9e8bf32b63c48d1c2cf49b91e0668b0085ae708eaf4e580
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
